United Biosource Corporation Financial Analyst Salaries in Baltimore, MD
The average United Biosource Corporation Financial Analyst in Baltimore, MD earns an estimated $75,998 annually, which includes an estimated base salary of $70,498 with a $5,500 bonus. United Biosource Corporation's Financial Analyst compensation is $11,402 less than the US average for a Financial Analyst. Financial Analyst salaries at United Biosource Corporation in Baltimore, MD can range from $50,000 - $89,000.
In Baltimore, MD, The Finance Department at United Biosource Corporation earns $2,339 more on average than the Business Development Department.
Last updated a year ago.
- $70,498
- avg. base
- $5,500
- avg. bonus
Financial Analyst Salaries at United Biosource Corporation
In Baltimore, MD, Financial Analysts earn $1,620 more than Business Analysts, and $9,113 less than Senior Accountants.
Compensation at United Biosource Corporation by Department
In Baltimore, MD, The Finance Department averages $2,339 more than the Business Development Department, and $4,892 less than the Legal Department
Financial Analyst Compensation by Gender (All Companies)
The average female Financial Analyst at companies similar size to United Biosource Corporation reported making $89,840, while the average male Financial Analyst at similar sized companies reported making $94,632.
Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Financial Analyst at companies similar size to United Biosource Corporation reported making $97,825, while the average African American/Black Financial Analyst at similar sized companies reported making $68,750.
How Financial Analysts at United Biosource Corporation Rate Their Compensation
The majority of Financial Analysts at United Biosource Corporation believe they're not compensated fairly. 100% of Financial Analysts at United Biosource Corporation say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at United Biosource Corporation
